Athens Medical Center S.A.

At Athens Medical Center S.A., the Pulmonology Department is involved in studies focused on respiratory tract diseases, especially idiopathic pulmonary fibrosis and progressive pulmonary fibrosis. These trials are exploring new ways to improve breathing function and slow disease progression in people with serious lung conditions.

• Idiopathic pulmonary fibrosis
• Progressive pulmonary fibrosis
• Improving lung function and treatment outcomes

The research aims to evaluate potential therapies that may help preserve forced vital capacity and support long-term respiratory health.

This site is also contributing to studies in cardiovascular diseases, with research centered on acute coronary syndrome and heart failure with systemic inflammation. The trials are designed to test new treatment options that could lower the risk of major heart-related events and improve outcomes for patients with complex cardiac disease.

• Acute coronary syndrome
• Heart failure with mildly reduced or preserved ejection fraction
• Reducing cardiovascular risk and disease complications

These investigations focus on whether emerging therapies can better protect patients from cardiovascular death, myocardial infarction, and worsening heart failure.

Clinical research at the Athens Medical Center S.A. includes nutritional and metabolic diseases, particularly obesity, overweight, and type 2 diabetes. These studies are examining innovative approaches to support weight loss and improve blood sugar control in adults living with metabolic disease.

• Obesity
• Overweight
• Type 2 diabetes

The goal is to assess whether new therapies can help reduce body weight, improve glycaemic control, and lower long-term health risks linked to metabolic disorders.

The site participates in trials within nervous system diseases, including research in multiple sclerosis. These studies are aimed at understanding long-term safety and tolerability of new treatments that may help manage disease activity and support patients with relapsing or progressive forms of the condition.

• Relapsing multiple sclerosis
• Progressive multiple sclerosis
• Evaluating safety and disease control

This area of research reflects a broader effort to improve care for people with chronic neurological disease through better treatment options.

Research in musculoskeletal diseases at this hospital includes studies of moderate to severe rotator cuff tendinopathy and active idiopathic inflammatory myopathy. These trials are assessing whether new therapies can ease symptoms, improve physical function, and offer better control of inflammatory disease.

• Moderate to severe rotator cuff tendinopathy
• Active idiopathic inflammatory myopathy
• Relieving pain and improving function

The overall focus is on testing treatments that may enhance mobility and quality of life for patients with both inflammatory and orthopedic conditions.